Siemens Healthineers AG (WBO:SHL) Interest Expense : €-476 Mil (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Siemens Healthineers AG's interest expense for the three months ended in Sep. 2024 was € -142 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was €-476 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Siemens Healthineers AG's Operating Income for the three months ended in Sep. 2024 was € 946 Mil. Siemens Healthineers AG's Interest Expense for the three months ended in Sep. 2024 was € -142 Mil. Siemens Healthineers AG's Interest Coverage for the quarter that ended in Sep. 2024 was 6.66. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Siemens Healthineers AG Interest Expense Historical Data

The historical data trend for Siemens Healthineers AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siemens Healthineers AG Interest Expense Chart

Siemens Healthineers AG Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Interest Expense

Get a 7-Day Free Trial

-76.00

-83.00

-118.00

-296.00

-476.00

Siemens Healthineers AG Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Interest Expense	Get a 7-Day Free Trial															-102.00	-107.00	-111.00	-116.00	-142.00

Siemens Healthineers AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-476 Mil.

Siemens Healthineers AG (WBO:SHL) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Siemens Healthineers AG's Interest Expense for the three months ended in Sep. 2024 was €-142 Mil. Its Operating Income for the three months ended in Sep. 2024 was €946 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was €513 Mil.

Siemens Healthineers AG's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2024 )	/	Interest Expense (Q: Sep. 2024 )
	=	-1	*	946	/	-142
	=	6.66

The higher the ratio, the stronger the company's financial strength is.

Siemens Healthineers AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (WBO:SHL) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

SEMHF:USA SMMNY:USA 1SHL:Italy SHLd:UK 0PMJ:UK SHL:Germany

Address

Siemensstr. 3, Forchheim, BY, DEU, 91301

Website

https://www.siemens-healthineers.com

Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2023) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (16% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (21%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. North America represents 41% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific including China the remainder.

Siemens Healthineers AG Headlines

No Headlines